Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model

Zika virus (ZIKV) infection is associated with serious, long-term neurological manifestations. There are currently no approved therapies for the treatment or prevention of ZIKV infection. Favipiravir (FAV) is a viral polymerase inhibitor with broad-spectrum activity. Our prior studies used static FA...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Pires de Mello, Camilly P., Tao, Xun, Kim, Tae Hwan, Vicchiarelli, Michael, Bulitta, Jürgen B., Kaushik, Ajeet, Brown, Ashley N.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2018
Teme:
Antiviral Agents
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125552/
https://ncbi.nlm.nih.gov/pubmed/29967017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00967-18
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki